Research News for June 12, 2019
advertisement
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes (see also: from TrialNet)
- Autoantibodies Directed to a Novel IA-2 Variant Protein Enhance Prediction of Type 1 Diabetes (HTML)
- Hemoglobin A1c Trajectory in Pediatric Patients with Newly Diagnosed Type 1 Diabetes (HTML)
- A New Animal Model of Insulin-Glucose Dynamics in the Intraperitoneal Space Enhances Closed-Loop Control Performance
- Incidence of severe hypoglycemia and possible associated factors in pediatric patients with type 1 diabetes mellitus in the real-life, post-DCCT setting: a systematic review (HTML)
- 3D printed polyamide macroencapsulation devices combined with alginate hydrogels for insulin-producing cell-based therapies (HTML)
- Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation (HTML | PDF)
- Hybrid Insulin Peptides are Autoantigens in Type 1 Diabetes (HTML)
- Efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double-blind, phase 3 trial (HTML)
- Maternal microchimerism in cord blood and risk of childhood-onset type 1 diabetes (HTML)
- Fatty Liver Among Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study) (HTML)
- Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes Registry (HTML)
- The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes (HTML)
- Abnormal Cortical and Trabecular Bone in Youth With Type 1 Diabetes and Celiac Disease (HTML)
- Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon (HTML)
- Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes (HTML)
